Recently identified factors predisposing children to infectious diseases

Current Opinion in Infectious Diseases

Volumn 21, Issue 3, 2008, Pages 217-222

  Arkwright, Peter D ^a,c   Abinun, Mario ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c BOOTH HALL CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Children; Immunodeficiency; Infection; Toll like receptors; Virulence

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CHEMOKINE RECEPTOR CXCR1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 12; INTERLEUKIN 23; PNEUMOCOCCUS VACCINE; STAT1 PROTEIN; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; VIRULENCE FACTOR; X LINKED INHIBITOR OF APOPTOSIS;

ACUTE PYELONEPHRITIS; ANTIBIOTIC RESISTANCE; BACTERIAL VIRULENCE; BRONCHIOLITIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; EPSTEIN BARR VIRUS; GENE MUTATION; GENETIC VARIABILITY; HERPES SIMPLEX ENCEPHALITIS; HOST SUSCEPTIBILITY; HUMAN; HYPER IGE SYNDROME; IMMUNE DEFICIENCY; INFECTION; INFECTION RISK; INNATE IMMUNITY; MEDICAL RESEARCH; NEUTROPENIA; NEUTROPHIL; NONHUMAN; OCULAR ALBINISM; PATHOPHYSIOLOGY; PHENOTYPIC VARIATION; PLASMODIUM FALCIPARUM; PREVALENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS INFECTION;

BACTERIAL OUTER MEMBRANE PROTEINS; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; DISEASE SUSCEPTIBILITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, NATURAL; INFANT; MUTATION; POLYMORPHISM, GENETIC; RISK FACTORS; VIRULENCE FACTORS;

EID: 42949176169     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3282fa1824     Document Type: Review

References (49)

1. Quintana-Murci L, Alcais A, Abel L, Casanova J-L. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat Immunol 2007; 8:1165-1171.
2. Geha RS, Notarangelo LD, Casanova JL, et al. Primary immunodeficiency diseases: An update from the International Union of Immunological Societies Primary Immunodeficiency diseases Classification Committee. J Allergy Clin Immunol 2007; 120:776-794. Up-to-date International Union of Immunological Societies (IUIS) classification of primary immunodeficiency diseases.
3. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007; 449:819-826.
4. Ku CL, Yang K, Bustamante J, et al. Inherited disorders of human Toll-like receptor signalling: immunological implications. Immunol Rev 2005; 203:10-20.
5. Ku CL, von Bernuth H, Picard C, et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med 2007; 204:2407-2422.
6. Filipe-Santos O, Bustamante J, Haverkamp MH, et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med 2006; 203:1745-1759.
7. Bustamante J, Picard C, Fieschi C, et al. A novel X-linked recessive form of Mendelian susceptibility to mycobacterial disease. J Med Genet 2007; 44:e65.
8. Zhang SY, Jouanguy E, Ugolini S, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007; 317:1522-1527. This article demonstrates the critical importance of TLR3 specifically to our immunity to herpes simplex virus.
9. Casrouge A, Zhang SY, Eidenschenk C, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006; 314:308-312.
10. Jouanguy E, Zhang SY, Chapgier A, et al. Human primary immunodeficiencies of type I interferons. Biochemie 2007; 89:878-883.
11. Tal G, Mandelberg A, Dalal I, et al. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 2004; 189:2057-2063.
12. Tulic MK, Hurrelbrink RJ, Prêle CM, et al. TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J Immunol 2007; 179:132-140. The study improves our understanding of how polymorphisms in TLRs lead to impaired immunity to the RSV virus and thus why some infants develop a more severe clinical course of RSV bronchiolitis.
13. Sadeghi K, Berger A, Langgartner M, et al. Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 2007; 195:296-302.
14. Minegishi Y, Saito M, Morio T, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006; 25:745-755.
15. Chapgier A, Wynn RF, Jouanguy E, et al. Human complete STAT-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J Immunol 2006; 176:5078-5083.
16. Minegishi Y, Saito S, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007;448:1058-1063. Joint first description of the genetic cause of autosomal dominant hyper IgE syndrome. Forty years after this condition was initially described, we finally understand the molecular basis for this multisystem disease.
17. Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007; 357:1-12. Joint first description of the genetic cause of autosomal dominant hyper IgE syndrome.
18. Renner ED, Torgerson TR, Rylaarsdam S, et al. STAT3 mutation in the original patient with Job's syndrome. N Engl J Med 2007; 357:1668-1669.
19. Von Bernuth H, Ku CL, Rodriguez-Gallego C, et al. A fast procedure for the detection of defects in Toll-like receptor signalling. Pediatrics 2006; 118:2498-2503.
20. Ku CL, Picard C, Erdos M, et al. IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease. J Med Genet 2007; 44:16-23.
21. Hirschfeld AF, Bettinger JA, Victor RE, et al. Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection. Clin Immunol 2007; 122:271-278. Fifty children with a history of invasive pneumococcal disease were screened for defects in TLR activity. No abnormalities were found. The authors suggest that routine clinical screening for TLR defects in otherwise healthy children who develop an invasive pneumococcal infection is probably not justified.
22. Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2007; 39:86-92.
23. Fontana S, Parolini S, Vermi W, et al. Innate immunity defects in Hermansky-Pudlak type 2 syndrome. Blood 2006; 107:4857-4864.
24. Bohn G, Allroth A, Brandes G, et al. A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med 2007; 13:38-45.
25. Lundstedt AC, Leijonhufvud I, Ragnarsdottir B, et al. Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J Infect Dis 2007; 195:1227-1234. This study provides evidence that defects in neutrophil chemotaxis to areas of infection because of abnormalities of the IL-8 chemokine receptor (CXCR1) is a significant cause of acute pyelonephritis in children and other affected family members.
26. Pasvolsky R, Feigelson SW, Kilic SS, et al. ALAD-III syndromeis associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils and platelets. J Exp Med 2007; 204:1571-1582.
27. Rigaud S, Fondanèche MC, Lambert N, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006; 444:110-114.
28. Canani RB, Cirillo P, Roggero P, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community acquired pneumonia in children. Pediatrics 2006; 117:e817-e820.
29. Lowenthal A, Livni G, Amir J, et al. Secondary bacteremia after rotavirus gastroenteritis in infancy. Pediatrics 2006; 117:224-226.
30. Roberts JL, Lauritsen JP, Cooney M, et al. T-B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3zeta subunit of the T-cell antigen receptor complex. Blood 2007; 109:3198-3206.
31. Rieux-Laucat F, Hivroz C, Lim A, et al. Inherited and somatic CD3ζ mutations in a patient with T-cell deficiency. N Engl J Med 2006; 354:1913-1921.
32. Giliani S, Bonfim C, de Saint Basile G, et al. Omenn syndrome in an infant with IL7RA gene mutation. J Pediatr 2006; 148:272-274.
33. Feske S, Gwack Y, Prakriya M, et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006; 441:179-185.
34. Van der Burg M, van Veelen LR, Verkaik NS, et al. A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation. J Clin Invest 2006; 116:137-145.
35. Buck D, Malivert L, de Chasseval R, et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 2006; 124:287-299.
36. Glocker E, Ehl S, Grimbacher B. Common variable immunodeficiency in children. Curr Opin Pediatr 2007; 19:685-692.
37. Dobbs AK, Yang T, Farmer D, et al. Cutting edge: a hypomorphic mutation in Igbeta (CD79b) in a patient with immunodeficiency and a leaky defect in B cell development. J Immunol 2007; 179:2055-2059.
38. Ferrari S, Lougaris V, Caraffi S, et al. Mutations of the Igbeta gene cause agammaglobulinemia in man. J Exp Med 2007; 3:2047-2051.
39. van Zelm MC, Reisli I, van der Burg M, et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006; 354:1901-1912.
40. Winkelstein JA, Marino MC, Lederman HM, et al. X-linked agammaglobulinaemia: report on a United States registry of 201 patients. Medicine 2006; 85:193-202.
41. Rogers S, Commons R, Danchin MH, et al. Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections. J Infect Dis 2007; 195:1625-1633.
42. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 2007; 298:1772-1778.
43. Fortunov RM, Hulten KG, Hammerman WA, et al. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics 2006; 118:874-881.
44. Faden H, Rose R, Lesse A, et al. Clinical and molecular characteristics of staphylococcal skin abscesses in children. J Pediatr 2007; 151:700-703.
45. Epstein SL. Prior H1N1 influenza infection and susceptibility of Cleveland family study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 2006; 193:49-53.
46. Sleeman KL, Griffiths D, Shackley F, et al. Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis 2006; 194:682-688.
47. Fowler VG, Nelson CL, McIntyre LM, et al. Potential associations between hematogenous complications and bacteria genotype in Staphylococcus aureus infection. J Infect Dis 2007; 196:738-747.
48. Kaestli M, Cockburn IA, Cortés A, et al. Virulence of malaria is associated with differential expression of Plasmodium falciparum var gene subgroups in a case-control study. J Infect Dis 2006; 193:1567-1574.
49. Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science 2007; 317:617-619.